ESR1 and invasive breast carcinoma: These heterogeneous tumors comprise 12–17% of all invasive breast cancers (BCa) and are characterized by lack of expression of estrogen receptor (ER), progesterone receptor (PR) and absence of HER2/neu overexpression or gene amplification (3).